Clinical Trials Browser

Brachytherapy × Gynecologic × Clear all

NCT07061977 2026-05-26

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Phase 3 Recruiting

Locally Advanced Cervical Adenocarcinoma

NCT02595879 2026-04-29

Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

Phase 1 Active not recruiting

21 enrolled 22 charts

Uterine Cervical Neoplasms

NCT03277469 2026-04-22

Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer

Phase NA Active not recruiting

Gynecologic Cancer

NCT03634267 2026-04-15

MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer

Phase 1 Active not recruiting

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT02466971 2026-04-13

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Phase 3 Active not recruiting

450 enrolled 11 charts

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT05570422 2026-04-08

A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01

Phase 1 Recruiting

Uterine Cervical Neoplasms

NCT02865837 2026-03-27

VESICOL

Phase NA Completed

Uterine Cervical Neoplasms

NCT07276360 2026-03-27

HypoRTCx-UG

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT03315351 2026-03-13

TEP-Curie

Phase NA Completed

Uterine Cervical Neoplasms

NCT03256916 2026-02-24

NELCER

Phase 3 Completed

Uterine Cervical Neoplasms

NCT04221945 2026-02-20

KEYNOTE-A18

Phase 3 Completed

1,060 enrolled 30 charts 1 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT03955978 2026-01-06

TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer

Phase 1 Active not recruiting

Endometrial Neoplasms

NCT06331468 2025-12-26

Hypofractionated Radiochemotherapy

Phase 2 Recruiting

Uterine Cervical Neoplasms, Uterine Neoplasms

NCT03422198 2025-12-12

SAVE

Phase 3 Recruiting

188 enrolled 15 charts

GynecologicSarcoma

Endometrial Clear Cell Adenocarcinoma

NCT07232654 2025-12-01

Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT03738228 2025-11-12

Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer

Phase 1 Completed

40 enrolled 17 charts

Uterine Cervical Neoplasms

NCT00924027 2025-09-05

A Study of Patients Receiving High-Dose Rate Brachytherapy

Phase 2 Completed

43 enrolled 13 charts

GastrointestinalGenitourinaryGynecologic

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT06543576 2025-08-15

External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer

Phase 1/2 Recruiting

Cervical Adenocarcinoma

NCT07121543 2025-08-13

Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy

Uterine Cervical Neoplasms

NCT02635360 2025-07-03

Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer

Phase 2 Completed

94 enrolled 16 charts

Uterine Cervical Neoplasms

NCT04634877 2025-06-09

KEYNOTE-B21

Phase 3 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

NCT05994300 2025-06-08

Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer

Phase NA Active not recruiting

Uterine Cervical Neoplasms, Radiation Injuries

NCT05857631 2025-04-15

PARCERII

Phase NA Recruiting

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06882473 2025-03-18

A Clinical Study of Pelvic Concurrent Chemoradiotherapy Combined with CT-guided Intracavitary Brachytherapy with Adaptive Simultaneous Dose Escalation for Locally Advanced Cervical Cancer

Phase NA Not yet recruiting

Locally Advanced Cervical Cancer

NCT06752135 2024-12-30

HRCC1

Uterine Cervical Neoplasms

NCT06288373 2024-10-30

Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC

Phase 2/3 Recruiting

Uterine Cervical Neoplasms

NCT03830866 2024-07-26

CALLA

Phase 3 Completed

770 enrolled 12 charts

Locally Advanced Cervical Cancer

NCT06419673 2024-05-17

Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer

Phase 2 Active not recruiting

Uterine Cervical Neoplasms

NCT06333821 2024-03-27

A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma

Phase 3 Not yet recruiting

Uterine Cervical Neoplasms

NCT05173272 2023-12-27

Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT01041027 2023-10-26

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer

Phase 2 Terminated

31 enrolled 8 charts

Endometrial Adenocarcinoma

NCT00411138 2023-10-11

PORTEC-3

Phase 3 Unknown

Endometrial Neoplasms

NCT05406856 2023-10-11

PROTECT

Phase NA Recruiting

Uterine Cervical Neoplasms

NCT01367301 2023-08-21

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer

Phase NA Terminated

14 enrolled 5 charts

GynecologicSarcoma

Stage IA Uterine Sarcoma

NCT05879796 2023-05-30

Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer

Uterine Cervical Neoplasms

NCT04336683 2023-05-17

Feasibility Study for Ultrasound-Guided Interstitial Brachytherapy for Gynecological CancersV2

Phase NA Completed

Gynecologic Cancer

NCT05799469 2023-04-05

Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT00492778 2023-03-29

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer

Phase 2 Unknown

165 enrolled 15 charts

Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation

NCT05772377 2023-03-16

Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer

Phase 2 Unknown

To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer

NCT01399658 2023-03-14

AMIGO

Phase 2 Completed

93 enrolled 5 charts

Uterine Cervical Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT05210270 2023-01-31

HYACINCT

Phase 1/2 Not yet recruiting

Locally Advanced Cervical Carcinoma

NCT01414608 2022-11-07

Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer

Phase 3 Completed

926 enrolled 13 charts

Uterine Cervical Neoplasms

NCT04772001 2022-05-18

Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer

Phase NA Unknown

Uterine Cervical Neoplasms

NCT00376844 2022-04-12

PORTEC-2

Phase 3 Completed

Endometrial Neoplasms

NCT03956498 2022-03-24

FEMINICOL

Phase NA Completed

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT03955367 2022-02-23

Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer

Phase 3 Unknown

Uterine Cervical Neoplasms

NCT05242861 2022-02-16

RetroBT

Uterine Cervical Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT05105672 2021-12-28

A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT00942357 2021-10-19

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

Phase 3 Unknown

813 enrolled 14 charts

Endometrial Clear Cell Adenocarcinoma

NCT04767425 2021-02-23

Image Guided Brachytherapy in Locally Advanced Cancer Cervix

Phase NA Unknown

Uterine Cervical Neoplasms